Gene · 5339
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer. | Transl Cancer Res | 2023 | 37969400 | PubTator, text mining | PubMed |
| Deep learning of human polyadenylation sites at nucleotide resolution reveals molecular determinants of site usage and relevance in disease. | Nat Commun | 2023 | 37968271 | PubTator, text mining | PubMed |
| Characteristics of HPV integration in cervical adenocarcinoma and squamous carcinoma. | J Cancer Res Clin Oncol | 2023 | 37966613 | PubTator, text mining | PubMed |
| Histatin 1-modified SIS hydrogels enhance the sealing of peri-implant mucosa to prevent peri-implantitis. | iScience | 2023 | 37965149 | PubTator, text mining | PubMed |
| Bioinformatic analysis of smoothelin family members supports tissue-specific functions of unique C-terminal calponin homology domains. | Physiol Rep | 2023 | 37960982 | PubTator, text mining | PubMed |
| An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients. | Int J Mol Sci | 2023 | 37958942 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomic Technology and Its Application to Study Skeletal Muscle Cell Biology. | Cells | 2023 | 37947638 | PubTator, text mining | PubMed |
| MePMe-seq: antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing. | Nat Commun | 2023 | 37935679 | PubTator, text mining | PubMed |
| Whole exome sequencing identifies common mutational landscape of cervix and endometrium small cell neuroendocrine carcinoma. | Front Oncol | 2023 | 37920164 | PubTator, text mining | PubMed |
| Sirtuin 2 promotes human cytomegalovirus replication by regulating cell cycle progression. | mSystems | 2023 | 37916830 | PubTator, text mining | PubMed |
| Comparison between the acoustic fundamental frequency of the voice and the vibration frequency of the vocal folds analyzed by digital kymography. | Codas | 2023 | 37909493 | PubTator, text mining | PubMed |
| Alkali metal doped crystalline g-C3N4 with an enriched cyano group for visible-light photocatalytic degradation of methylamine. | RSC Adv | 2023 | 37908663 | PubTator, text mining | PubMed |
| Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. | Life (Basel) | 2023 | 37895357 | PubTator, text mining | PubMed |
| STS and PUDP Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review. | Genes (Basel) | 2023 | 37895274 | PubTator, text mining | PubMed |
| Molecular Mechanisms for the Regulation of Nuclear Membrane Integrity. | Int J Mol Sci | 2023 | 37895175 | PubTator, text mining | PubMed |
| The Endothelial Centrosome: Specific Features and Functional Significance for Endothelial Cell Activity and Barrier Maintenance. | Int J Mol Sci | 2023 | 37895072 | PubTator, text mining | PubMed |
| Decoding Hidden Messengers: Proteomic Profiling of Exosomes in Mammary Cancer Research. | Biomedicines | 2023 | 37893211 | PubTator, text mining | PubMed |
| Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum. | PLoS One | 2023 | 37883475 | PubTator, text mining | PubMed |
| Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing. | JAMA Netw Open | 2023 | 37878314 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5339/papers?page=10